Endogenous multiple exon skipping and back-splicing at the DMD mutation hotspot

Hitoshi Suzuki, Yoshitsugu Aoki, Toshiki Kameyama, Takashi Saito, Satoru Masuda, Jun Tanihata, Tetsuya Nagata, Akira Maeda, Shin’Ichi Takeda, Toshifumi Tsukahara

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45–55 of the DMD gene, might improve patients’ symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45–55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44–56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction (RT-PCR), and identified a total of eight types of MES products around the hotspot. Surprisingly, the 50 splice sites of recently reported post-transcriptional introns (remaining introns after co-transcriptional splicing) act as splicing donor sites for MESs. We also tested exon combinations to generate DMD circular RNAs (circRNAs) and determined the preferential splice sites of back-splicing, which are involved not only in circRNA generation, but also in MESs. Our results fit the current circRNA-generation model, suggesting that upstream post-transcriptional introns trigger MES and generate circRNA because its existence is critical for the intra-intronic interaction or for extremely distal splicing.

Original languageEnglish
Article number1722
JournalInternational Journal of Molecular Sciences
Volume17
Issue number10
DOIs
Publication statusPublished - 13-10-2016

Fingerprint

splicing
Duchenne Muscular Dystrophy
mutations
RNA
Exons
Mutation
Polymerase chain reaction
Transcription
Muscle
Genes
Introns
polymerase chain reaction
skeletal muscle
deletion
genes
upstream
actuators
disorders
products
Reverse Transcription

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Suzuki, Hitoshi ; Aoki, Yoshitsugu ; Kameyama, Toshiki ; Saito, Takashi ; Masuda, Satoru ; Tanihata, Jun ; Nagata, Tetsuya ; Maeda, Akira ; Takeda, Shin’Ichi ; Tsukahara, Toshifumi. / Endogenous multiple exon skipping and back-splicing at the DMD mutation hotspot. In: International Journal of Molecular Sciences. 2016 ; Vol. 17, No. 10.
@article{481a920749c446f18e26289bfc21b74d,
title = "Endogenous multiple exon skipping and back-splicing at the DMD mutation hotspot",
abstract = "Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45–55 of the DMD gene, might improve patients’ symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45–55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44–56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction (RT-PCR), and identified a total of eight types of MES products around the hotspot. Surprisingly, the 50 splice sites of recently reported post-transcriptional introns (remaining introns after co-transcriptional splicing) act as splicing donor sites for MESs. We also tested exon combinations to generate DMD circular RNAs (circRNAs) and determined the preferential splice sites of back-splicing, which are involved not only in circRNA generation, but also in MESs. Our results fit the current circRNA-generation model, suggesting that upstream post-transcriptional introns trigger MES and generate circRNA because its existence is critical for the intra-intronic interaction or for extremely distal splicing.",
author = "Hitoshi Suzuki and Yoshitsugu Aoki and Toshiki Kameyama and Takashi Saito and Satoru Masuda and Jun Tanihata and Tetsuya Nagata and Akira Maeda and Shin’Ichi Takeda and Toshifumi Tsukahara",
year = "2016",
month = "10",
day = "13",
doi = "10.3390/ijms17101722",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

Suzuki, H, Aoki, Y, Kameyama, T, Saito, T, Masuda, S, Tanihata, J, Nagata, T, Maeda, A, Takeda, SI & Tsukahara, T 2016, 'Endogenous multiple exon skipping and back-splicing at the DMD mutation hotspot', International Journal of Molecular Sciences, vol. 17, no. 10, 1722. https://doi.org/10.3390/ijms17101722

Endogenous multiple exon skipping and back-splicing at the DMD mutation hotspot. / Suzuki, Hitoshi; Aoki, Yoshitsugu; Kameyama, Toshiki; Saito, Takashi; Masuda, Satoru; Tanihata, Jun; Nagata, Tetsuya; Maeda, Akira; Takeda, Shin’Ichi; Tsukahara, Toshifumi.

In: International Journal of Molecular Sciences, Vol. 17, No. 10, 1722, 13.10.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endogenous multiple exon skipping and back-splicing at the DMD mutation hotspot

AU - Suzuki, Hitoshi

AU - Aoki, Yoshitsugu

AU - Kameyama, Toshiki

AU - Saito, Takashi

AU - Masuda, Satoru

AU - Tanihata, Jun

AU - Nagata, Tetsuya

AU - Maeda, Akira

AU - Takeda, Shin’Ichi

AU - Tsukahara, Toshifumi

PY - 2016/10/13

Y1 - 2016/10/13

N2 - Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45–55 of the DMD gene, might improve patients’ symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45–55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44–56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction (RT-PCR), and identified a total of eight types of MES products around the hotspot. Surprisingly, the 50 splice sites of recently reported post-transcriptional introns (remaining introns after co-transcriptional splicing) act as splicing donor sites for MESs. We also tested exon combinations to generate DMD circular RNAs (circRNAs) and determined the preferential splice sites of back-splicing, which are involved not only in circRNA generation, but also in MESs. Our results fit the current circRNA-generation model, suggesting that upstream post-transcriptional introns trigger MES and generate circRNA because its existence is critical for the intra-intronic interaction or for extremely distal splicing.

AB - Duchenne muscular dystrophy (DMD) is a severe muscular disorder. It was reported that multiple exon skipping (MES), targeting exon 45–55 of the DMD gene, might improve patients’ symptoms because patients who have a genomic deletion of all these exons showed very mild symptoms. Thus, exon 45–55 skipping treatments for DMD have been proposed as a potential clinical cure. Herein, we detected the expression of endogenous exons 44–56 connected mRNA transcript of the DMD using total RNAs derived from human normal skeletal muscle by reverse transcription polymerase chain reaction (RT-PCR), and identified a total of eight types of MES products around the hotspot. Surprisingly, the 50 splice sites of recently reported post-transcriptional introns (remaining introns after co-transcriptional splicing) act as splicing donor sites for MESs. We also tested exon combinations to generate DMD circular RNAs (circRNAs) and determined the preferential splice sites of back-splicing, which are involved not only in circRNA generation, but also in MESs. Our results fit the current circRNA-generation model, suggesting that upstream post-transcriptional introns trigger MES and generate circRNA because its existence is critical for the intra-intronic interaction or for extremely distal splicing.

UR - http://www.scopus.com/inward/record.url?scp=84991662200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991662200&partnerID=8YFLogxK

U2 - 10.3390/ijms17101722

DO - 10.3390/ijms17101722

M3 - Article

C2 - 27754374

AN - SCOPUS:84991662200

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

M1 - 1722

ER -